Company / R&D per Share
GRAIL, Inc. R&D per Share History
FY2022-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$10.91
FY2023
5-year range
$10.61 / $10.91
FY2022-FY2023
Trend
+2.8%
vs FY2022
Sector context
#1 of 108
Health Care
What the data says
Among 108 Health Care companies, GRAIL, Inc. is in the top 1% for r&d per share.
Based on SEC 10-K filings.
10.91 in FY2023. Ranks 1st among 108 companies in Health Care.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 1% in Health CareTop 1% of 108This company $10.91 Sector average $2.07
▼
+426.9% above sector average
Key checks
Key Insights
- In FY2023, r&d per share increased 2.8% year-over-year.
- Ranks #1 out of 108 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -0.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $10.91 | +2.8% |
| FY2022 | $10.61 | - |
As of FY2023 · SEC 10-K · Updated Mar 28, 2026